Frontlight ResearchEarly access
Trial site
Holden Comprehensive Cancer Center
- 7running trials
- 3closed trials
The trials here
What the 10 trials at this site are about, from their registry records.
- Conditions
- Neuroendocrine tumours3 trials
- Gastric and oesophageal cancer2 trials
- Glioblastoma2 trials
- Lung cancer2 trials
- Cervical cancer1 trial
- Childhood cancers1 trial
- Diffuse large B-cell lymphoma1 trial
- Hodgkin lymphoma1 trial
- Melanoma1 trial
- Multiple myeloma1 trial
- Pancreatic cancer1 trial
- Prostate cancer1 trial
- and 1 more
- Phase
- Phase 23 trials
- Early phase 12 trials
- Phase 12 trials
- Phase 1/21 trial
- Phase 31 trial
- Status
- Active, not recruiting4 trials
- Completed2 trials
- Recruiting2 trials
- Enrolling by invitation1 trial
- Withdrawn1 trial
- Lead sponsor
- David Bushnell2 trials
- Andrew P. Groves1 trial
- Arcus Biosciences, Inc.1 trial
- Astellas Pharma Global Development, Inc.1 trial
- Bryan Allen1 trial
- and 4 more
Running trials
Recruiting
Enrolling by invitation
Intrathecal Azacitidine and Nivolumab in Patients With Recurrent High-grade Glioma
Recruiting
A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer
Active, not recruiting
Active, not recruiting
Gallium 68 Pentixafor in Patients With Neuroendocrine Tumors
Active, not recruiting
Active, not recruiting
A Phase 2 Trial of High-Dose Ascorbate in Glioblastoma Multiforme
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Childhood cancers1 recruiting
- Gastric and oesophageal cancer1 recruiting
- Glioblastoma1 recruiting
- Prostate cancer1 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 12 Nov 2026